The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers.
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Patrick M. Forde
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Celgene
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
Kellie Nicole Smith
No Relationships to Disclose
 
Valsamo Anagnostou
No Relationships to Disclose
 
Tricia Cottrell
No Relationships to Disclose
 
Janis M. Taube
No Relationships to Disclose
 
Natasha Rekhtman
No Relationships to Disclose
 
Taha Merghoub
No Relationships to Disclose
 
David Randolph Jones
No Relationships to Disclose
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech/Roche
 
Stephen C. Yang
No Relationships to Disclose
 
Stephen Broderick
Consulting or Advisory Role - Bristol-Myers Squibb
 
Valerie W. Rusch
Research Funding - Genelux (Inst)
Travel, Accommodations, Expenses - da Vinci Surgery
 
Victor E. Velculescu
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - Personal Genome Diagnostics
Consulting or Advisory Role - Ignyta; Janssen Diagnostics; Personal Genome Diagnostics; Quintiles
Patents, Royalties, Other Intellectual Property - Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Genzyme.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Myriad.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Personal Genome Diagnostics.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Qiagen.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Roche.
 
Suzanne Louise Topalian
Stock and Other Ownership Interests - Aduro Biotech (I); Compugen (I); Five Prime Therapeutics; Jounce Therapeutics (I); NexImmune (I); Potenza Therapeutics (I)
Consulting or Advisory Role - Amgen (I); Five Prime Therapeutics; GlaxoSmithKline; Inanovate; Jounce Therapeutics; MedImmune (I); Merck (I); Pfizer (I); Potenza Therapeutics (I); Sanofi (I)
Research Funding - Bristol-Myers Squibb; Compugen (I); Potenza Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Aduro Biotech (I); Bristol-Myers Squibb (I); Potenza Therapeutics (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Five Prime Therapeutics
 
Drew M. Pardoll
Stock and Other Ownership Interests - Aduro Biotech; Compugen; Jounce Therapeutics; Neximmune; Potenza Therapeutics
Consulting or Advisory Role - Amgen; Medimmune; Merck; Pfizer; Sanofi
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Compugen; Potenza Therapeutics
Patents, Royalties, Other Intellectual Property - Royalties on patents licensed to Aduro, BMS, Potenza
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck